GLA’s Chairman, Paul Ross interviews ozone therapy specialist Dr. Robbins, along with a Lyme patient, Charles Toepher who has experience with the treatment.
“Recognizing the importance of evaluating novel treatment options for chronic Lyme disease patients, GLA is funding a study of the effects of ozone on Lyme bacteria at world-renowned Tufts University.”- Timothy Sellati Ph.D., Chief Scientific Officer, GLA.